Comprehensive profiling of lipid metabolic reprogramming expands precision medicine for HCCQingbin Liu, Shulong Jiang, Peng Xiu et al.|Hepatology|2024Cited by 60
Therapeutic effect and transcriptome-methylome characteristics of METTL3 inhibition in liver hepatocellular carcinomaQingbin Liu, Shulong Jiang, Yong Yu et al.|Cancer Cell International|2023Cited by 15
Extrachromosomal DNA (ecDNA) drives hepatocellular carcinoma malignancy through high-copy amplification of chromosome 1q21-derived PIP5K1A oncogeneNi Zhang, Shulong Jiang, Changlin Ma et al.|Cancer Letters|2025Cited by 2
Therapeutic effect and transcriptome-methylome characteristics of METTL3 inhibition in liver hepatocellular carcinomaQingbin Liu, Shulong Jiang, Weiyang Li et al.|Research Square|2023Cited by 1